Developmental process of DGPPN quality indicators;Entwicklungsprozess der DGPPN-Qualitätsindikatoren

Nervenarzt

Volumn 84, Issue 3, 2013, Pages 350-365

  Grossimlinghaus I ^a   Falkai, P ^b   Gaebel, W ^a   Janssen, B ^a   Reich Erkelenz, D ^b   Wobrock, T ^c,d   Zielasek, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Zentrum für Seelische Gesundheit   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

German Association for Psychiatry and Psychotherapy; Psychiatry; Quality indicators; Quality measurement; Trans sectoral

Indexed keywords

ARTICLE; GERMAN ASSOCIATION FOR PSYCHIATRY AND PSYCHOTHERAPY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; MEDICAL SOCIETY; MENTAL DISEASE; MENTAL HEALTH CARE; PRACTICE GUIDELINE; PSYCHIATRIC DIAGNOSIS;

GERMANY; HUMANS; MENTAL DISORDERS; NEUROLOGY; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; PSYCHOTHERAPY;

EID: 84879835977     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-012-3705-4     Document Type: Article

References (100)

1. Altenhofen L, Blumenstock G, Diel F et al (2009) Programm für Nationale VersorgungsLeitlinien von BÄK, KBV und AWMF - Qualitätsindikatoren Manual für Autoren. Ärztliches Zentrum für Qualität im Gesundheitswesen (ÄZQ)
2. AQUA-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH. Allgemeine Methoden im Rahmen der sektorenübergreifenden Qualitätssicherung im Gesundheitswesen nach § 137a SGB V Version 2.0 Stand: 30. Juni 2010. Letzter Zugriff 05.07.2012 von http://www.sqg.de/hintergrundinformation/methodenpapier/index.html
3. Deutsche Rentenversicherung (DRV) (2008) Leitlinie für die stationäre und teilstationäre Rehabilitation bei Alkoholabhä ngigkeit. Pilotversion 2008. Letzter Zugriff am 19.12.2012 von www.suchthilfe.de
4. DGPPN (2012) Eine deutschlandweite Ressource zur Erforschung psychischer Erkrankungen. Presse-Information Nr.11/11.04.2012. Letzter Zugriff 25.04.2012 von http://www.dgppn.de/aktuelles/detailansicht/article/100/eine-deutsch.html
5. DGPPN, BÄK, KBV, AWMF et al (Hrsg) (2009) S3-Leitlinie/Nationale Versorgungsleitlinie "Unipolare Depression" (NVL). Konsultationsfassung Version 1.2. www.depression.versorgungsleitlinie.de
6. DGPPN, DGN (Hrsg) (2009) S3-Leitlinie "Demenzen", Langfassung Stand 11/2009. Letzter Zugriff am 19.12.2012 von www.awmf.org/leitlinien/detail/ ll/038-013.html
7. DGPPN, DG-Sucht (Hrsg) (2003) Akutbehandlung alkoholbezogener Störungen. Sucht 49:147-167
8. DGPPN (Hrsg) (2006) Praxisleitlinien in Psychiatrie und Psychotherapie. Bd. 1 Behandlungsleitlinie Schizophrenie. Steinkopff, Darmstadt
9. Gaebel W, Becker T, Janssen B et al (2012) EPA guidance on the quality of mental health services. Eur Psychiatry 27:87-113
10. Gemeinsamer Bundesausschuss (G-BA) (2012) Beschluss des Gemeinsamen Bundesausschusses über eine Beauftragung der Institution nach § 137a SGB V: Entwicklung eines sektorenübergreifenden Qualitä tssicherungsverfahrens zur Versorgung bei psychischen Erkrankungen vom 15.03.2012
11. Gemeinsamer Bundesausschuss (G-BA) (2010) Richtlinie des Gemeinsamen Bundesausschusses nach § 92 Abs. 1 Satz 2 Nr. 13 i.V.m. § 137 Abs. 1 Nr. 1 SGB V über die einrichtungs- und sektorenübergreifenden Maßnahmen der Qualitätssicherung: (Richtlinie zur einrichtungs- und sektorenübergreifenden Qualitätssicherung - Qesü-RL) vom 19.04.2010, veröffentlicht im Bundesanzeiger 2010 S. 3995, in Kraft getreten am 02.12.2010
12. Geyer D, Batra A, Beutel M et al (2006) AWMF Leitlinie: Postakutbehandlung alkoholbezogener Störungen. Sucht 52:8-34
13. Muche-Borowski C, Kopp I (2011) Wie eine Leitlinie entsteht. Z Herz Thorax Gefäßchir 25:217-223
14. National Institute for Health and Clinical Excellence (2010) Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (updated edition). The British Psychological Society & The Royal College of Psychiatrists. Letzter Zugriff am 19.12.2012 von http://guidance.nice.org.uk/CG82/Guidance/pdf/English
15. Reiter A, Fischer B, Kötting J et al (2007) QUALIFY: Ein Instrument zur Bewertung von Qualitätsindikatoren. Bundesgeschäftsstelle Qualitätssicherung gGmbH. Letzter Zugriff am 19.12.2012 von www.bqs-institut.de/innovationen/ qualify-instrument.html
16. Schmidt LG et al (2006) Deutsche Gesellschaft für Suchtforschung und Suchttherapie e. V. (DG-Sucht) (Hrsg) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie substanzbezogene Störungen. Deutscher Ärzte-Verlag GmbH, Köln
17. Scottish Intercollegiate Guidelines Network (SIGN) (2003) The management of harmful drinking and alcohol dependence in primary care. A national clinical guideline. September 2003 Updated 2004. Letzter Zugriff am 19.12.2012 von www.sign.ac.uk/guidelines/fulltext/ 74/index.html
18. Spaeth-Rublee B, Pincus HA, Huynh PT et al (2010) Measuring quality of mental health care: a review of initiatives and programs in selected countries. Can J Psychiatry 55: 539-548
19. Wobrock T, Reich-Erkelenz D, Janssen B et al (2010) Qualitä tsindikatoren in der Psychiatrie. Psychiatrie 7:1-11
20. Zielasek J, Großimlinghaus I, Janssen B et al (2012) Die Rolle von Qualitätsindikatoren in der psychiatrischen Qualitätssicherung und aktueller Stand der Entwicklung von Qualitätsindikatoren. Die Psychiatrie 9:46-52
21. Hermann R et al (2006) Quality indicators for international benchmarking of mental health care. Int J Qual Health Care 18:31-38
22. Center for quality assessment and improvement in mental health (CQAIMH) Indicator Set. Letzter Zugriff am 25.04.12 von http://www.cqaimh.org/NIMHQM.htm
23. Kassenärztliche Bundesvereinigung (Hrsg) (2009) KBV entwickelt Starter-Set ambulanter Qualitätsindikatoren. Ergebnisse des Projekts "AQUIK - Ambulante Qualitätsindikatoren und Kennzahlen". Kassenärztliche Bundesvereinigung. Letzter Zugriff am 26.04.2012 von http://www.kbv.de/aquik.html
24. Feil D, MacLean C, Sultzer D (2007) Quality indicators for the care of dementia in vulnerable elders. JAGS 55:293-30 (RAND ACOVE-3 Quality Indicators)
25. Hermann R et al (2004) Selecting Indicators for the Quality of Mental Health Care at the Health Systems Level in OECD Countries. OECD Health Technical Paper No. 17. Letzter Zugriff am 25.04.2012 von http://www.oecd.org/ dataoecd/28/32/33865630.pdf
26. Weinmann S, Becker T (2009) Qualitätsindikatoren für die Integrierte Versorgung von Menschen mit Schizophrenie. Psychiatrie-Verlag, Bonn
27. Lora A et al (2008) Project SIEP-DIRECT'S indicators for assessing discrepancies between routine practice and evidence in psychiatric community treatments provided to people with schizophrenia. Societa Italiana Di Epidemiologia Psychiatrica S.I.E.P. Letzter Zugriff am 25.04.2012 von http://www.psychiatry.univr.it/page-eps/docs/2008-4-Instrument-2.pdf
28. Miller WR, Rollnick S (Hrsg) (1999). Motivierende Gesprächsfü hrung - ein Konzept zur Beratung von Menschen mit Suchtproblemen. Lambertus, Freiburg
29. Miller WR, Wilbourne PL (2002) Mesa grande: a methodological analysis of clinical trials for treatment of alcohol use disorders. Addiction 97:265-277
30. Andréasson S, Öjehagen A (2003) Psychosocial treatment for alcohol dependenc. In: Berglund M, Thelander S, Jonsson E (eds) Treating alcohol and drug abuse. An evidence based review. WILEY-VCH, Weinheim, S 43-188
31. Morgenstern J, Longabaugh R (2000) Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction 95:1475-1490
32. Babor TF, Del Boca FK (eds) (2003) Treatment matching in alcoholism. Cambridge Univ Press
33. Gossop M et al (2003) Is attendance at alcoholics anonymous meetings after inpatient treatment related to improved outcomes? A 6-month follow-up study. Alcohol Alcohol 38:421-426
34. McKay JR (2001) The role of continuing care in outpatient alcohol treatment programs. Recent Dev Alcohol 15:357-72
35. Anton RF et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. JAMA 295:2003-2017
36. Kiefer F et al (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiat 60:92-99
37. Krampe H et al (2011) Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcohol Clin Exp Res 35:1732-1736
38. Kranzler HR, Van Kirk J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alc Clin Exp Res 25:1335-1341
39. Laaksonen E et al (2008) A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:53-54
40. De Sousa AA, De Sousa JA (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-548
41. De Sousa AA, De Sousa JA (2008). An open randomised trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat 34:460-463
42. Nunes EV, Levin FR (2001) Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 291:1887-1896
43. Randall CL et al (2001) Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety 14:255-262
44. Henkel D, Zemlin U, Dornbusch P (2004) Analyse rü ckfallbeeinflussender Bedingungen bei arbeitslosen Alkoholabhängigen (ARA-Projekt) - Teil II: Ergebnisse des Therapieverlaufs und der 6-Monatskatamnese. Sucht aktuell 11:21-32
45. Comerford AW (1999) Work dysfunction and addiction: Common roots. J Subst Abuse Treat 16:247-253
46. Ihl R et al (2000) Entwicklung und Validierung eines Tests zur Früherkennung der Demenz mit Depressionsabgrenzung (TFDD). Fortschr Neurol Psychiatr 68:413-422
47. Thompson S et al (2007) Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Can J Psychiatry 52:248-255
48. Roth M et al (1996) Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 168:149-157
49. Krueger CE et al (2009). Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia and Alzheimer's disease.Alzheimer Dis Assoc 24:43-48
50. Mitchell AJ (2009) A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairement. J Psychiatr Res 43:411-431
51. Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546-1554
52. McKeith IG et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872
53. Birks J (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1:CD005593
54. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) (Hrsg) (2007) Cholinesterasehemmer bei Alzheimer Demenz. Abschlussbericht A05-19 A (Version 1.0, Stand: 07.02.2007). Köln
55. Winblad B et al (2006) 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord 21:353-363
56. Ballard C, Hanney ML, Theodoulou M et al (2009) The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 8:151-157
57. Ballard C, Lana MM, Theodoulou M et al (2008) A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med 5:e76
58. Brodaty H et al (2003) A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64:134-143
59. Schneider LS et al (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14:191-210
60. Rudolf S et al (2006) Diagnostik depressiver Störungen in Praxis und klinischem Alltag. Dtsch Arztebl 103:A-1754-1762
61. Whooley MA et al (1997) Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12:439-445
62. Loh A et al (2007) Patientenbeteiligung bei medizinischen Entscheidungen - Effekte der partizipativen Entscheidungsfindung aus systematischen Reviews. Dtsch Arztebl 104:A1483-1488
63. O'Connor AM et al (2009) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 3:CD001431
64. Woltersdorf M (2002) Krankheit Depression. Erkennen, verstehen und behandeln. Psychiatrie-Verlag, Bonn
65. Arroll B et al (2005) Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 3:449-456
66. Lotufo-Neto F, Trivedi M, Thase ME (1999) Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 20:226-247
67. Mulrow CD et al (2000) Efficacy of newer medications for treating depression in primary care patients. Am J Med 108:54-64
68. Keller MB et al (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462-1470
69. Pampallona S et al (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 61:714-719
70. Thase ME et al (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 54:1009-1015
71. Sutej I et al (2006) Pharmakotherapie und Psychotherapie bei unipolarer Depression. Ist die kombinierte Behandlung einer Monotherapie überlegen? Z Psychia Psych Psychother 54:163-172
72. Gloaguen V et al (1998) A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 49:59-72
73. The UK ECT review group (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:799-808
74. Motto JA, Bostrom AG (2001) A randomized controlled trial of postcrisis suicide prevention. Psychiatr Serv 52:828-833
75. Gaebel W et al (2011) Relapse prevention in first-episode schizophrenia - maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry 72:205-218
76. Lehman AF et al (1998) Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 24:1-10
77. Lehman AF et al (2004) The Schizophrenia Patient Outcome Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull 30:193-217
78. Mitchell et al (2011) Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 10:1-23
79. De Hert et al (2011) Physical illness in patients with severe mental disorders. II. barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10:138-151
80. De Hert et al (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD), and the European Society of Cardiology (ESC). Eur Psychiatry 24:412-424
81. Buchkremer G, Klingberg S, Holle R et al (1997) Psychoeducational psychotherapy for schizophrenicpatients and their key relatives or care-givers: results of a 2-year follow up. Acta Psychiatr Scand 96:483-491
82. Cormac et al (2003) Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev Issue 1, 2003. 2001
83. Garety PA, Fowler DG, Freeman D et al (2008) Cognitive-behavioral therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomized controlled trial. BJPsych 192:412-423
84. Gould et al (2001) Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res 48:335-342
85. Jackson HJ, MCGorry PD, Killackey E et al (2008) Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychological Medicine 38:725-735
86. Pilling et al (2002) Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 32:763-782
87. Wykes T et al (2008) Cognitive behavioral therapy for schizophrenia: effects sizes, clinical models, and methodological rigor. Schizophr Bull 34:523-537
88. Pekkala E, Merinder (2002) Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2:CD002831
89. Xia J et al (2011) Psychoeducation for schizophrenia. Schizophr Bull 37:21-22
90. Rummel-Kluge, Kissling (2008) Psychoeducation in schizophrenia: new developments and approaches in the field. Curr Opin Psychiatry 21:168-172
91. Greenberg GA, Rosenheck RA (2005) Continuity of care and clinical outcomes in a national health system. Psychiatr Serv 56:427-433
92. Ilgen et al (2008) Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders. Psychiatr Serv 59:982-988
93. Munk-Jorgensen P, Mors O et al (2000) The schizophrenic patient in the somatic hospital. Acta Psychiatr Scand 102 (Suppl 407):96-99
94. Nordentoft M et al (2002) OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry 43:98-106
95. Siris SG (1991) Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophr Bull 17:75-98
96. Babidge NC, Buhrich N, Butler T (2001) Mortality among homeless people with schizophrenia in Sydney, Australia: a 10-year follow-up. Acta Psychiatr Scand 103:105-110
97. Pharoah F et al (2010) Family Intervention for schizophrenia. Cochrane Database Syst Rev 12:CD000088
98. Catty J et al (2008) Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. Br J Psychiatry 192:224-231
99. Crowther R et al (2001) Vocational rehabilitation for people with severe mental illness. Cochrane Database Syst Rev 2:CD003080
100. Lehman AF et al (2002) Improving employment outcomes for persons with severe mental illnesses. Arch Gen Psychiatry 59:165-172